Teva Board Members Take 50% Pay Cut Post author:Sam Post published:January 10, 2018 Post category:BioPharma Teva has made a target of cutting costs by $3B by the end of 2019. Source: BioSpace You Might Also Like Late-Stage Life Sciences Investment Firm, Aisling Capital, Closes $280M Fund November 1, 2017 Novartis Eyes 2019 for Launch of Investigational nAMD treatment February 21, 2018 Warning: These Could be the Top 3 Most Overrated Biotech Stocks June 18, 2017
